IUPAC name
[1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonic acid
SMILES
OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O
Compound class
Bone Density Conservation Agents; Calcium Channel Blockers; Antihypocalcemic Agents; Antiresorptives; Bisphosphonates; Musculo-Skeletal System; Drugs Affecting Bone Structure and Mineralization; Drugs for Treatment of Bone Diseases;
Therapeutic area
For the treatment of Paget's disease of the bone (osteitis deformans), postmenopausal and glucocorticoid-induced osteoporosis.
Common name
Risedronate
IUPAC name
[1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonic acid
SMILES
OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O
INCHI
InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)
FORMULA
C7H11NO7P2
Common name
Risedronate
IUPAC name
[1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonic acid
Molecular weight
283.112
clogP
-2.666
clogS
0.970
HBond Acceptor
8
HBond Donor
5
Total Polar Surface Area
148.18
Number of Rings
1
Rotatable Bond
4
